Rachel Radwan

On day 1 of the NCCN 2026 Annual Conference, attendees heard from experts on the unique issues young adults with cancer face during and post-treatment, advances in treating gastrointestinal cancers, evolving therapies in skin cancers, and novel approaches to treating blood cancers.

In an effort to improve outcomes and deliver the highest quality of care to patients with pancreatic cancer, Duke Cancer Institute launched a multidisciplinary Pancreatic Cancer Center that prioritizes thorough surveillance of high-risk patients, stays at the forefront of clinical trials, and considers the role of comorbidities.

Electronic patient-reported outcomes (ePROs) can address limited visibility into patients' health and well-being between visits. Yet, many solutions remain generic in their workflows and mainly help capture adverse events, without helping care teams proactively manage or prevent them from worsening. Cureety offers a new kind of ePRO solution, specialized in oncology and designed to make care better quality, more efficient, and more proactive for all patients.

Patients with rare diseases and their families often feel isolated and overlooked, with many medical questions left unanswered and few people who can empathize with their condition. Rare Disease Day is observed globally each year to bring awareness for diseases and the people behind them by promoting the challenges these rare medical journeys pose for patients and caregivers.

For 52 years, the ACCC has pursued its mission to provide resources, forums, and opportunities to promote the delivery of high-quality, equitable cancer care. Learn more about the work of ACCC over the past year in the full 2025 Impact Report.

This January, ACCC invites its membership to take part in promoting cervical cancer awareness by sharing resources and research about the importance of the HPV vaccine and regular screening, to work towards a future free of cervical cancer.

To broaden access to the specialized support and navigation that patients with primary brain tumors need, the Brain Tumor Network partnered with the American Cancer Society.

Introducing Oncology Unscripted, ACCC’s new CANCER BUZZ podcast, which offers unfiltered, honest dialogue about the future of cancer care delivery and fresh perspectives on how oncology professionals can think bigger, lead smarter, and act bolder.

In honor of the great sacrifice of Veterans and first responders and in pursuit of improving awareness, health literacy, and availability of assistance programs, the NCCN hosted a patient advocacy summit on December 9, 2025, in the nation’s capital.

In honor of National Oncology Navigator Day, ACCC is pleased to share several initiatives from cancer programs across the country who are leveraging navigators in creative and successful ways.

The final day of the 42nd National Oncology Conference featured panels that brought together leaders and innovators to discuss clinical and administrative priorities, coordinating with primary care, and challenges in rural and remote communities.

Day 2 of the 42nd National Oncology Conference (NOC) offered powerful insights about creating a trusting and engaged workforce, making the business case for an innovation, and the presentations of the six 2025 Innovator Award Winners.

Day 1 of the ACCC 42nd National Oncology Conference (NOC) featured discussions of psychosocial care and a fireside chat with ACCC President, Una Hopkins, DNP, MSN, FNP-BC, NE-BC, RN, FACCC.

In recognition of the importance of mental well-being and mental health services, ACCC highlights 3 thought leadership pieces featured in recent volumes of Oncology Issues that tackle mental health–forward interventions for both patients and providers.

The recent NCCN summit provided an opportunity for providers, payers, and patient advocates to discuss policy and strategies on the current application of AI in practice, its promise for care improvement, and strategies to mitigate the risks AI poses.

Leaders at Mary Bird Perkins Cancer Center have rebuilt their now nationally recognized clinical trials program from the ground up, with diverse enrollment a cornerstone of their philosophy.

To learn more about her background, her work in the health care space, and what to expect from her keynote at the upcoming NOC, ACCCBuzz spoke with Dr. Salgado about her 2 decades of experience making employees feel engaged and invested.

Recognizing the weight of the barriers to trial participation, Susan G. Komen partnered with breastcancertrials.org to develop a free clinical trials navigation e-course designed to help patient navigators better support individuals in accessing trials.

After witnessing patients struggle to access comprehensive, in-home support services such as palliative care and hospice, the team at Shaw Cancer Center developed Shaw at Home, an oncology specific home and community-based palliative care program.

Fox Chase Cancer Center earned a 2025 ACCC Innovator Award for its Ambulatory Care Excellence Model, which improved efficiency, coordination, and patient outcomes in ambulatory cancer care while ensuring top-of-license scope of work for clinicians.

In recognition of patients' struggle to navigate a fragmented health care system throughout their cancer treatment, the NCCN hosted a policy summit dedicated to strengthening coordination between primary care providers and oncologists.

An early contributor to evidence supporting the impact of remote patient monitoring, Highlands Oncology received a 2025 ACCC Innovator Award for its sustainable, scalable remote patient monitoring model.

Mercy is transforming cancer care through technology that is both innovative and patient-centric, and its 4-year funding award from PCORI positions this program to reach a broader patient population than ever before.

In this third blog of the 2025 ACCC Innovator Award series, Bart Daugherty from Lifepoint Health shares more about his program's initiative to improve the quality of preventive care for patients in rural communities.